DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 2822--------------------------------------------------
       (Abst.) ANCA-associated life-threatening systemic vasculitis aft
       er alemtuzumab treatment for MS
       By: agate Date: February 23, 2020, 7:20 pm
       ---------------------------------------------------------
       From PubMed (February 23, 2020), "ANCA-associated
       life-threatening systemic vasculitis after alemtuzumab treatment
       for multiple sclerosis"
  HTML https://www.ncbi.nlm.nih.gov/pubmed/32081100
       ANCA vasculitis:
       [quote][font=Roboto]ANCA vasculitis is an autoimmune disease
       affecting small blood vessels in the body. It is caused by
       autoantibodies called ANCAs, or
       [/font][font=Roboto][/size]A[/font][font=Roboto][/size]nti-[/fon
       t][font=Roboto][/size]N[/font][font=Roboto][/size]eutrophilic
       [/font][font=Roboto][/size]C[/font][font=Roboto][/size]ytoplasmi
       c
       [/font][font=Roboto][/size]A[/font][font=Roboto][/size]utoantibo
       dies.
       ANCAs target and attack a certain kind of white blood cells
       called neutrophils. They target a part of neutrophils called the
       cytoplasm (the inside of the cell.)[/font][/quote]
       [from the UNC Kidney Center Website]
       *****************************************************